46.80000 EUR
1
2.09%
Last update Dec 16, 7:30 PM CET
Market closed
Day range
46.40000
47
Previous close
47.80000
Open
47
Access this stock data via API
Subscribe
Crispr Therapeutics AG
46.80
1
2.09%

Statistics

Valuation metrics
Market cap
0
Enterprise value
-63.55M
Trailing P/E (ttm)
-10.78
Forward P/E
PEG ratio
-0.68
Price/Sales (ttm)
0
Price/Book (mrq)
2.23
Enterprise Value/Revenue
-2.13
Enterprise Value/EBITDA
0.17
Overview
Shares outstanding
93.87M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
6
Average volume (90 days)
6
Price summary
52-Week low
29.20
52-Week high
68.50
52-Week change
16.24 55.6%
Beta
50-Day moving average
51.21
200-Day moving average
44.52
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
-215.00%
Operating margin
-1,333.05%
Operational effectiveness
Return on assets
-16.34%
Return on equity
-18.96%
Income statement
Revenue (ttm)
29.83M
Revenue per share (ttm)
0.41
Quarterly revenue growth (yoy)
Gross profit (ttm)
-64.13M
EBITDA
0
Net income to common (ttm)
-312.14M
Diluted EPS (ttm)
-4.34
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
179.85M
Total Debt/Equity (mrq)
0.11
Current ratio (mrq)
1,621.67%
Book value per share (mrq)
20.98
Cash flow
Cash flow statement
-102.93M
Levered free cash flow (LFCF)
-312.14M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 3 hours 18 minutes

04:41
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).